HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TWNK
twinkle mtDNA helicase
Chromosome 10 Β· 10q24.31
NCBI Gene: 56652Ensembl: ENSG00000107815.10HGNC: HGNC:1160UniProt: A0A2R8Y4V4
144PubMed Papers
23Diseases
0Drugs
82Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protease bindingmitochondrial DNA replicationmitochondrial transcriptionprotein hexamerizationprogressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3mitochondrial DNA depletion syndrome 7 (hepatocerebral type)Perrault syndrome 5mitochondrial disease
✦AI Summary

TWNK encodes Twinkle, a mitochondrial DNA (mtDNA) helicase that plays a crucial role in mtDNA replication and maintenance 1. The protein functions as part of the core mtDNA replisome alongside DNA polymerase Ξ³ and single-stranded DNA binding protein, essential for maintaining mitochondrial genome integrity 2. TWNK is involved in mitochondrial DNA maintenance defects (MDMDs), a group of diseases caused by pathogenic variants in nuclear genes involved in mtDNA synthesis 3. Mutations in TWNK result in impaired mtDNA synthesis leading to quantitative depletion and qualitative defects including multiple mtDNA deletions 3. The gene is associated with several clinical conditions including Perrault syndrome, an autosomal recessive disorder characterized by sensorineural hearing loss, ovarian dysfunction in females, and often neurological abnormalities 14. TWNK variants also cause autosomal dominant progressive external ophthalmoplegia (adPEO) and have been implicated in premature ovarian insufficiency 56. Due to variable mtDNA copy numbers across tissues, TWNK pathogenic variants result in a wide spectrum of clinical manifestations with notable heterogeneity, particularly affecting energy-sensitive organs like the nervous system 1. Recent studies have also identified potential associations with Parkinson's disease 7.

Sources cited
1
TWNK encodes Twinkle helicase crucial for mtDNA replication and maintenance, and causes Perrault syndrome
PMID: 40669787
2
TWNK is part of core mtDNA replisome essential for mitochondrial genome integrity
PMID: 33087282
3
TWNK mutations cause mitochondrial DNA maintenance defects with quantitative and qualitative mtDNA abnormalities
PMID: 28215579
4
TWNK mutations cause auditory neuropathy and Perrault syndrome phenotypes
PMID: 39936838
5
TWNK is associated with primary ovarian insufficiency
PMID: 34794894
6
TWNK variants show haploinsufficiency effects in premature ovarian insufficiency
PMID: 37349538
7
TWNK variants have been identified in Parkinson's disease patients
PMID: 35792653
Disease Associationsβ“˜23
progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3Open Targets
0.82Strong
mitochondrial DNA depletion syndrome 7 (hepatocerebral type)Open Targets
0.82Strong
Perrault syndrome 5Open Targets
0.81Strong
mitochondrial diseaseOpen Targets
0.51Moderate
progressive external ophthalmoplegia with mitochondrial DNA deletionsOpen Targets
0.41Moderate
autosomal dominant progressive external ophthalmoplegiaOpen Targets
0.38Weak
Perrault syndrome 2Open Targets
0.37Weak
mitochondrial DNA depletion syndrome, hepatocerebrorenal formOpen Targets
0.37Weak
Perrault syndrome 1Open Targets
0.37Weak
Sensory ataxic neuropathy - dysarthria - ophthalmoparesisOpen Targets
0.34Weak
progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1Open Targets
0.34Weak
sensory ataxic neuropathy, dysarthria, and ophthalmoparesisOpen Targets
0.34Weak
auditory neuropathyOpen Targets
0.34Weak
third-degree atrioventricular blockOpen Targets
0.33Weak
progressive external ophthalmoplegiaOpen Targets
0.27Weak
depressive disorderOpen Targets
0.27Weak
Bilateral ptosisOpen Targets
0.27Weak
DysphoniaOpen Targets
0.27Weak
EMG: myopathic abnormalitiesOpen Targets
0.27Weak
Sensorineural hearing impairmentOpen Targets
0.27Weak
Mitochondrial DNA depletion syndrome 7UniProt
Perrault syndrome 5UniProt
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3UniProt
Pathogenic Variants82
NM_021830.5(TWNK):c.1453T>A (p.Phe485Ile)Likely pathogenic
not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
β˜…β˜…β˜†β˜†2026β†’ Residue 485
NM_021830.5(TWNK):c.907C>T (p.Arg303Trp)Pathogenic
not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
β˜…β˜…β˜†β˜†2025β†’ Residue 303
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease|Infantile onset spinocerebellar ataxia|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
β˜…β˜…β˜†β˜†2025β†’ Residue 334
NM_021830.5(TWNK):c.1462_1463del (p.Phe488fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 488
NM_021830.5(TWNK):c.1075G>A (p.Ala359Thr)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 359
NM_021830.5(TWNK):c.1120C>T (p.Arg374Trp)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 374
NM_021830.5(TWNK):c.853C>T (p.Arg285Ter)Pathogenic
not provided|Infantile onset spinocerebellar ataxia
β˜…β˜…β˜†β˜†2025β†’ Residue 285
NM_021830.5(TWNK):c.1121G>A (p.Arg374Gln)Pathogenic
Mitochondrial disease|not provided|8 conditions|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
β˜…β˜…β˜†β˜†2025β†’ Residue 374
NM_021830.5(TWNK):c.1523A>G (p.Tyr508Cys)Pathogenic
Infantile onset spinocerebellar ataxia|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 508
NM_021830.5(TWNK):c.1070G>C (p.Arg357Pro)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 357
NM_021830.5(TWNK):c.85C>T (p.Arg29Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 29
NM_021830.5(TWNK):c.967C>T (p.Arg323Ter)Pathogenic
not provided|Infantile onset spinocerebellar ataxia
β˜…β˜…β˜†β˜†2025β†’ Residue 323
NM_021830.5(TWNK):c.1110C>G (p.Phe370Leu)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 370
NM_021830.5(TWNK):c.1198C>T (p.Arg400Cys)Likely pathogenic
not provided|Mitochondrial disease
β˜…β˜…β˜†β˜†2024β†’ Residue 400
NM_021830.5(TWNK):c.1342A>G (p.Asn448Asp)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 448
NM_021830.5(TWNK):c.1106C>A (p.Ser369Tyr)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
β˜…β˜…β˜†β˜†2024β†’ Residue 369
NM_021830.5(TWNK):c.649C>T (p.Arg217Ter)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 217
NM_021830.5(TWNK):c.1060C>T (p.Arg354Cys)Likely pathogenic
not provided|Infantile onset spinocerebellar ataxia
β˜…β˜…β˜†β˜†2024β†’ Residue 354
NM_021830.5(TWNK):c.1433T>G (p.Phe478Cys)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 478
NM_021830.5(TWNK):c.1422G>C (p.Trp474Cys)Pathogenic
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 474
View on ClinVar β†—
Related Genes
SLC25A4Protein interaction88%DGUOKProtein interaction88%RNASEH1Protein interaction87%TFB2MProtein interaction85%MRPL43Protein interaction81%GABPAProtein interaction79%
Tissue Expression6 tissues
Liver
100%
Ovary
97%
Heart
85%
Brain
68%
Bone Marrow
54%
Lung
51%
Gene Interaction Network
Click a node to explore
TWNKSLC25A4DGUOKRNASEH1TFB2MMRPL43GABPA
PROTEIN STRUCTURE
Preparing viewer…
PDB7T8B Β· 3.80 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.76LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.58 [0.44–0.76]
RankingsWhere TWNK stands among ~20K protein-coding genes
  • #3,184of 20,598
    Most Researched144 Β· top quartile
  • #904of 5,498
    Most Pathogenic Variants82 Β· top quartile
  • #6,080of 17,882
    Most Constrained (LOEUF)0.76
Genes detectedTWNK
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Genetics of ovarian insufficiency and defects of folliculogenesis.
PMID: 34794894
Best Pract Res Clin Endocrinol Metab Β· 2022
1.00
2
Mitochondrial DNA maintenance defects.
PMID: 28215579
Biochim Biophys Acta Mol Basis Dis Β· 2017
0.90
3
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
0.80
4
TWNK gene pathogenic variant and Perrault syndrome.
PMID: 40669787
Gene Β· 2025
0.70
5
Penetrance of pathogenic genetic variants associated with premature ovarian insufficiency.
PMID: 37349538
Nat Med Β· 2023
0.60